Success Metrics

Clinical Success Rate
85.4%

Based on 82 completed trials

Completion Rate
85%(82/96)
Active Trials
11(9%)
Results Posted
37%(30 trials)
Terminated
14(11%)

Phase Distribution

Ph not_applicable
19
15%
Ph phase_3
25
20%
Ph phase_2
20
16%
Ph phase_4
32
26%
Ph early_phase_1
4
3%
Ph phase_1
21
17%

Phase Distribution

25

Early Stage

20

Mid Stage

57

Late Stage

Phase Distribution121 total trials
Early Phase 1First-in-human
4(3.3%)
Phase 1Safety & dosage
21(17.4%)
Phase 2Efficacy & side effects
20(16.5%)
Phase 3Large-scale testing
25(20.7%)
Phase 4Post-market surveillance
32(26.4%)
N/ANon-phased studies
19(15.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.8%

82 of 104 finished

Non-Completion Rate

21.2%

22 ended early

Currently Active

11

trials recruiting

Total Trials

124

all time

Status Distribution
Active(12)
Completed(82)
Terminated(22)
Other(8)

Detailed Status

Completed82
Terminated14
unknown8
Recruiting8
Withdrawn8
Active, not recruiting3

Development Timeline

Analytics

Development Status

Total Trials
124
Active
11
Success Rate
85.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (3.3%)
Phase 121 (17.4%)
Phase 220 (16.5%)
Phase 325 (20.7%)
Phase 432 (26.4%)
N/A19 (15.7%)

Trials by Status

completed8266%
unknown86%
active_not_recruiting32%
recruiting86%
terminated1411%
not_yet_recruiting11%
withdrawn86%

Recent Activity

11 active trials
Showing 5 of 124
recruiting

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

NCT03511118
completedphase_2

A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans

NCT01243437
completedphase_3

A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia (FOVOCIP)

NCT07616635
recruitingphase_2

Antibiotic Prophylaxis for Neurogenic Bladder Botox

NCT04791579
completedphase_4

Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia

NCT04948463
View all 124 trials

Clinical Trials (124)

Showing 20 of 124 trialsScroll for more
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT01243437Phase 2

A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans

Completed
NCT07616635Phase 3

A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia (FOVOCIP)

Completed
NCT04791579Phase 2

Antibiotic Prophylaxis for Neurogenic Bladder Botox

Recruiting
NCT04948463Phase 4

Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia

Completed
NCT04678869Not Applicable

CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia)

Active Not Recruiting
NCT05294588Phase 2

Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae

Completed
NCT05274672Phase 4

Role of Prophylactic Postoperative Antibiotics in HoLEP

Withdrawn
NCT05100654Early Phase 1

Collaborative Urological Prosthetics Investigation Directive Research Group

Active Not Recruiting
NCT06426836Not Applicable

Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

Recruiting
NCT03012360Phase 4

Antimicrobial Treatment in Patients With Ventilator-associated Tracheobronchitis

Terminated
NCT03850379Phase 2

Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant

Completed
NCT05846399Phase 4

CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)

Recruiting
NCT04523987Phase 1

A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.

Active Not Recruiting
NCT05844735Phase 1

A Randomized Placebo- and Active Comparator-controlled Study to Evaluate the Photosafety of SAR441566

Completed
NCT04444440Phase 4

Antibiotic Prophylaxis for Bladder Botox

Recruiting
NCT07150065Phase 2

Efficacy of Levofloxacin Versus Ciprofloxacin in the Treatment of Childhood Typhoid Fever

Completed
NCT07016165Phase 4

Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies

Recruiting
NCT07028424Phase 2

PANORAMIX : Optimizing 1st-line NALIRIFOX and Exploring Microbiota's Role in 2nd Line Pancreatic Cancer Treatment

Not Yet Recruiting
NCT01753115Phase 2

Ciprofloxacin BioThrax Co-Administration Study

Completed

Drug Details

Intervention Type
DRUG
Total Trials
124